Exploitation of the Apoptosis-Primed State of MYCN-Amplified Neuroblastoma to Develop a Potent and Specific Targeted Therapy Combination

  • Jungoh Ham, Carlotta Costa, Renata Sano, Timothy L. Lochmann, Erin M. Sennott, Neha U. Patel, Anahita Dastur, Maria Gomez-Caraballo, Kateryna Krytska, Aaron N. Hata, Konstantinos V. Floros, Mark T. Hughes, Charles T. Jakubik, Daniel A.R. Heisey, Justin T. Ferrell, Molly L. Bristol, Ryan J. March, Craig Yates, Mark A. Hicks, Wataru Nakajima, Madhu Gowda, Brad E. Windle, Mikhail G. Dozmorov, Mathew J. Garnett, Ultan McDermott, Hisashi Harada, Shirley M. Taylor, Iain M. Morgan, Cyril H. Benes, Jeffrey A. Engelman, Yael P. Mossé, Anthony C. Faber
  • Cancer Cell, February 2016, Elsevier
  • DOI: 10.1016/j.ccell.2016.01.002

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1016/j.ccell.2016.01.002